Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastro-oesophageal Adenocarcinoma”

533 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 533 results

Large-scale testing (Phase 3)UnknownNCT02780921
What this trial is testing

Effect of Prehabilitation in Gastroesophageal Adenocarcinoma: Study Protocol of a Multicentric, Randomised Control Trial

Who this might be right for
Oesophageal CancerGastric Cancer
University Hospital, Clermont-Ferrand 120
Testing effectiveness (Phase 2)UnknownNCT03941626
What this trial is testing

Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies

Who this might be right for
Esophagus CancerHepatomaGlioma+1 more
Shenzhen BinDeBio Ltd. 50
Large-scale testing (Phase 3)Study completedNCT02872116
What this trial is testing

Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer

Who this might be right for
Gastric CancerGastroesophageal Junction CancerEsophageal Adenocarcinoma
Bristol-Myers Squibb 2,031
Early research (Phase 1)Looking for participantsNCT07182149
What this trial is testing

NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Who this might be right for
HNSCCESCCEsophageal Adenocarcinoma+7 more
Normunity AccelCo, Inc. 150
Testing effectiveness (Phase 2)Ended earlyNCT05500508
What this trial is testing

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Who this might be right for
CancerSolid TumorSolid Carcinoma+17 more
Aminex Therapeutics, Inc. 15
Testing effectiveness (Phase 2)Looking for participantsNCT04150640
What this trial is testing

Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma

Who this might be right for
Esophageal AdenocarcinomaGastric Adenocarcinoma
University of Wisconsin, Madison 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439110
What this trial is testing

Testing Ado-Trastuzumab Emtansine as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol Q)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 38
Not applicableLooking for participantsNCT07224750
What this trial is testing

A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer

Who this might be right for
Hepatocellular Carcinoma (HCC)CholangiocarcinomaPancreatic Ductal Adenocarcinoma (PDAC)+3 more
City of Hope Medical Center 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT07818018
What this trial is testing

2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Esophageal CancerAdvanced Esophageal CancerGastric Cancer+5 more
Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Ended earlyNCT01870791
What this trial is testing

Study of Additive Omega-3 Fish Oil to Palliative Chemotherapy to Treat Oesophagogastric Cancer

Who this might be right for
Esophageal NeoplasmGastric Neoplasm
University Hospitals, Leicester 21
Early research (Phase 1)Study completedNCT01928524
What this trial is testing

Chemotherapy for Patients With Cancer of the Stomach

Who this might be right for
First-line Treatment for Patients With Non-resectable Gastric Cancer or Cancer of the Esophagus or
Per Pfeiffer 34
Testing effectiveness (Phase 2)Study completedNCT00165191
What this trial is testing

Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus

Who this might be right for
Adenocarcinoma of StomachAdenocarcinoma of GE JunctionAdenocarcinoma of Esophagus
Dana-Farber Cancer Institute 32
Early research (Phase 1)Study completedNCT06056024
What this trial is testing

Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus

Who this might be right for
Solid Tumor, KRAS Mutation
Boehringer Ingelheim 47
Not applicableLooking for participantsNCT06605404
What this trial is testing

Pan-tumor MRD Study

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaEsophageal CancerGastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+4 more
Paradigm Health 1,350
Testing effectiveness (Phase 2)UnknownNCT03399071
What this trial is testing

Study Title: Peri-operative Immuno-Chemotherapy in Operable Oesophageal and Gastric Cancer

Who this might be right for
Gastric AdenocarcinomaOesophageal Adenocarcinoma
Royal Marsden NHS Foundation Trust 44
Not applicableStudy completedNCT03301493
What this trial is testing

Genomic Testing and Resulting Medical Decisions

Who this might be right for
Cancer of Unknown OriginCancer RefractoryCancer of Stomach+12 more
Arbeitsgemeinschaft medikamentoese Tumortherapie 1,500
Testing effectiveness (Phase 2)Study completedNCT00004233
What this trial is testing

S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach

Who this might be right for
Esophageal CancerGastric Cancer
SWOG Cancer Research Network 65
Large-scale testing (Phase 3)Study completedNCT01726452
What this trial is testing

NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)

Who this might be right for
Adenocarcinoma of the OesophagusAdenocarcinoma of the Oesophago-gastric JunctionOesophageal Tumours+2 more
Cancer Trials Ireland 377
Post-approval studies (Phase 4)UnknownNCT01927328
What this trial is testing

Iron Replacement in Oesophagogastric Neoplasia

Who this might be right for
AnemiaEsophageal CancerGastric Cancer
Nottingham University Hospitals NHS Trust 40
Early research (Phase 1)Ended earlyNCT06560645
What this trial is testing

PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorNon-small Cell Lung Carcinoma+7 more
Prelude Therapeutics Incorporated 42
Next Page